Related Experiment Video
Updated: Jul 2, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Long-Term Effects of a Stepwise, Multimodal, Non-Restrictive Antimicrobial Stewardship Programme for Reducing
Mar Ronda1, Victor Daniel Gumucio-Sanguino2,3, Evelyn Shaw1,3,4
1Department of Infectious Diseases, Hospital Universitari de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
Abstract:
Information on the long-term effects of non-restrictive antimicrobial stewardship (AMS) strategies is scarce. We assessed the effect of a stepwise, multimodal, non-restrictive AMS programme on broad-spectrum antibiotic use in the intensive care unit (ICU) over an 8-year period. Components of the AMS were progressively implemented. Appropriateness of antibiotic prescribing was also assessed by monthly point-prevalence surveys from 2013 onwards. A Poisson regression model was fitted to evaluate trends in the reduction of antibiotic use and in the appropriateness of their prescription. From 2011 to 2019, a total of 12,466 patients were admitted to the ICU. Antibiotic use fell from 185.4 to 141.9 DDD per 100 PD [absolute difference, -43.5 (23%), 95% CI -100.73 to 13.73; p = 0.13] and broad-spectrum antibiotic fell from 41.2 to 36.5 [absolute difference, -4.7 (11%), 95% CI -19.58 to 10.18; p = 0.5]. Appropriateness of antibiotic prescribing rose by 11% per year [IRR: 0.89, 95% CI 0.80 to 1.00; p = 0.048], while broad-spectrum antibiotic use showed a dual trend, rising by 22% until 2015 and then falling by 10% per year since 2016 [IRR: 0.90, 95% CI 0.81 to 0.99; p = 0.03]. This stepwise, multimodal, non-restrictive AMS achieved a sustained reduction in broad-spectrum antibiotic use in the ICU and significantly improved appropriateness of antibiotic prescribing.
Insights
A stepwise, non-restrictive antimicrobial stewardship (AMS) program in the ICU reduced broad-spectrum antibiotic use and improved prescribing appropriateness over eight years. This study offers insights into long-term AMS strategy effects.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Public Health
Background:
- Limited data exists on the long-term impact of non-restrictive antimicrobial stewardship (AMS) strategies.
- Intensive care units (ICUs) are critical settings for monitoring antibiotic use due to high consumption and resistance risks.
- Evaluating sustained effects of AMS programs is essential for optimizing antibiotic use and combating antimicrobial resistance.
Purpose of the Study:
- To assess the long-term effects of a stepwise, multimodal, non-restrictive AMS program on antibiotic use in the ICU.
- To evaluate the impact of the AMS program on broad-spectrum antibiotic consumption.
- To determine changes in the appropriateness of antibiotic prescribing over an eight-year period.
Main Methods:
- A prospective, 8-year study (2011-2019) involving a stepwise implementation of a non-restrictive AMS program in an ICU.
- Antibiotic use was measured in DDD per 100 patient-days (PD).
- Monthly point-prevalence surveys assessed antibiotic prescribing appropriateness; Poisson regression analyzed trends.
Main Results:
- Overall antibiotic use decreased by 23% (from 185.4 to 141.9 DDD/100 PD).
- Broad-spectrum antibiotic use showed an initial increase followed by a sustained 10% annual reduction post-2016.
- Appropriateness of antibiotic prescribing significantly improved, increasing by 11% annually (p=0.048).
Conclusions:
- A stepwise, multimodal, non-restrictive AMS program can achieve sustained reductions in broad-spectrum antibiotic use in ICUs.
- The implemented AMS strategy significantly improved the appropriateness of antibiotic prescribing over the long term.
- This approach provides a viable model for optimizing antibiotic use in critical care settings without restrictive measures.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

